Metraipolis › archive › dc_e26c2f457ea0

Efficacy and safety analysis of treatment in patients with EGFR-mutated advanced NSCLC who progressed on TKIs: a systematic review and meta-analysis — Europe PMC PMID:41229435

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41229435
DOI
10.3389/fimmu.2025.1673115
License (as archived)
solo-consultazione
Archived
2026-10-08T09:57:56.102Z
SHA-256 of the archived text
d71fc74a66a66b66a726aa3fa6752bec6937c5156829d2f901bfde9830bb349c
Stable URL of this page
https://metraipolis.com/documento/dc_e26c2f457ea0

How to cite

Efficacy and safety analysis of treatment in patients with EGFR-mutated advanced NSCLC who progressed on TKIs: a systematic review and meta-analysis — Europe PMC PMID:41229435 — Europe PMC (en), https://europepmc.org/article/MED/41229435 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e26c2f457ea0 (Metraipolis archive dc_e26c2f457ea0, sha256 d71fc74a66a66b66a726aa3fa6752bec6937c5156829d2f901bfde9830bb349c)
BibTeX
@misc{dce26c2f457ea0,
  title = {Efficacy and safety analysis of treatment in patients with EGFR-mutated advanced NSCLC who progressed on TKIs: a systematic review and meta-analysis — Europe PMC PMID:41229435},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41229435},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e26c2f457ea0; sha256 d71fc74a66a66b66a726aa3fa6752bec6937c5156829d2f901bfde9830bb349c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41229435. Agents can read the archived copy with the MCP tool read_document.